Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test a combination-therapy of oxaliplatin and docetaxel in
patients with metastatic or locally advanced adenocarcinoma of the pancreas after failure of
a palliative first line therapy.